http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6322014-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 1986-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_654ddea542f30bf7e2781023400dae72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29adab8d288e21d15032c8b51d228739
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c396916ce7837baeddd5f57a8056ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37552464c23840362439c51e58c34134
publicationDate 1988-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6322014-A
titleOfInvention Long-acting capsule drug floating in stomach
abstract PURPOSE: To obtain the titled easily producible capsule drug having sufficiently high buoyancy and strength, by adding a drug-active component to molten polyethylene glycol, oil and fat, etc., filling the mixture in a hard capsule body soluble in stomach and closing the body with a cap insoluble in stomach leaving a space in the capsule. n CONSTITUTION: Molten polyethylene glycol and/or oil and fat (e.g. cacao fat, stearic acid, cetyl alcohol, etc.) is mixed with a drug-active component, preferably an oral drug desired to have prolonged activity (e.g. amoxicillin, cephalexin, etc.) or a polyethylene glycol or an oil or fat is mixed with a drug-active component under melting. The mixture is filled in a body of a hard capsule soluble in stomach and the body is closed with a hard capsule cap insoluble in stomach in a manner to leave a space (5W40% of the whole inner volume) in the capsule. n COPYRIGHT: (C)1988,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013530200-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6310719-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0051570-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017014257-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9314430-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8372428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10076500-B2
priorityDate 1986-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535016

Total number of triples: 35.